Summary & Overview
HCPCS J0122: Injection, Eravacycline, 1 mg
HCPCS Level II code J0122 identifies a 1 mg unit of eravacycline supplied for injection. As an intravenous antibiotic, eravacycline is used in clinical settings to treat certain serious bacterial infections; accurate coding of the drug units is essential for claims processing, inventory tracking, and cost analysis across hospital and outpatient infusion sites. Nationally, consistent use of J0122 supports standardized billing for eravacycline administration and aids payers and providers in reconciling drug acquisition and patient care costs.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of how the code is applied in clinical workflows, the common sites of service where eravacycline is administered, and what to expect in payer coverage context. The publication also outlines typical benchmarks and policy considerations relevant to drug unit coding, reimbursement implications for high-cost infused antibiotics, and related billing and documentation practices. Where specific data elements from payers or additional coding crosswalks are not provided in the input, the text notes that those items are not available.
Billing Code Overview
HCPCS Level II code J0122 represents an injection of eravacycline, 1 mg. This code describes the drug product and the administered unit of medication for intravenous infusion or injection as indicated by the drug description.
Service Type: Intravenous antibiotic administration
Typical Site of Service: Hospital inpatient, hospital outpatient infusion center, or other outpatient infusion settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized for a complicated intra-abdominal or severe community-acquired bacterial infection who requires intravenous broad-spectrum therapy. Eravacycline is administered as an intravenous infusion prepared from the J0122 billing unit (injection, eravacycline, 1 mg). The clinical workflow begins with infectious disease consultation and selection of eravacycline when pathogens or clinical risk factors (multidrug-resistant Gram-negative organisms, prior antibiotic exposure, or intolerance to other agents) warrant its use. Pharmacy compounds the exact dose based on patient weight and renal/hepatic status, labels the vial(s), and documents lot numbers. Nursing verifies the order, obtains intravenous access (peripheral or central), performs bedside time-out, and administers the infusion per institutional protocol (typically over 60 minutes depending on preparation). Post-infusion monitoring includes vital signs, assessment for infusion reactions, and documentation of dose, units administered (milligrams via J0122), and any adverse events. Billing captures J0122 units corresponding to the milligrams administered, with applicable modifiers for circumstances such as professional service, administration complexity, or discarded medication per standards.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|